8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Apr 13, 2026·SEC
Material company update
Feb 24, 2026·SEC
AdaptHealth Corp.(AHCO)Earnings, Financials & Key Ratios
AHCO•NASDAQ
Price updated Jun 19, 2026
AboutAdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.Show more
- Revenue$3.24B-0.5%
- EBITDA$599M-4.7%
- Net Income-$71M-178.3%
- EPS (Diluted)-0.52-185.2%
- Gross Margin17.52%-16.1%
- EBITDA Margin18.47%-4.3%
- Operating Margin5.74%-29.0%
- Net Margin-2.18%-178.7%
- ROE-4.56%-176.8%
AHCO Key Insights
AdaptHealth Corp. (AHCO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 15.2%
- ✓Strong 5Y sales CAGR of 25.2%
- ✓Trading at only 0.9x book value
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when AHCO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AHCO Price & Volume
AdaptHealth Corp. (AHCO) stock price & volume — 10-year historical chart
Loading chart...
AHCO Growth Metrics
AdaptHealth Corp. (AHCO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years25.16%
3 Years2.99%
TTM8.78%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-193.3%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-203.51%
Return on Capital
10 Years2.51%
5 Years1.86%
3 Years-0.69%
Last Year4.95%
AHCO Recent Earnings
AdaptHealth Corp. (AHCO) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 5, 2026Metric
Actual
Est
EPS
$0.06-580.0%
$0.01
Rev
$820M+2.9%
$797M
Q1 2026
Feb 24, 2026Metric
Actual
Est
EPS
$0.27-20.6%
$0.34
Rev
$846M+1.8%
$832M
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.22-8.3%
$0.24
Rev
$820M-1.5%
$833M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$0.01-93.3%
$0.15
Rev
$800M+0.2%
$799M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.06vs $0.01-580.0% | $820Mvs $797M+2.9% |
| Q1 2026 | Feb 24, 2026 | $0.27vs $0.34-20.6% | $846Mvs $832M+1.8% |
| Q4 2025 | Nov 4, 2025 | $0.22vs $0.24-8.3% | $820Mvs $833M-1.5% |
| Q3 2025 | Aug 5, 2025 | $0.01vs $0.15-93.3% | $800Mvs $799M+0.2% |
Based on last 12 quarters of dataView full earnings history →
AHCO Peer Comparison
AdaptHealth Corp. (AHCO) competitors in Device suppliers, distribution, and services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HCSG | 1.64B | 22.94 | 28.32 | 7.08% | 3.21% | 11.83% | 0.05 | |
 OPCH | 3.44B | 21.99 | 17.32 | 13.03% | 3.64% | 15.28% | ||
 EHAB | 706.91M | 13.80 | -152.32 | 2.44% | -0.3% | -0.55% | 0.89 | |
 PTCT | 6.55B | 78.98 | 10.15 | 114.51% | -22.58% | |||
 PHG | 25.5B | 26.78 | 25.02 | -1.04% | 5.49% | 8.96% | 0.74 | |
 ISRG | 144.48B | 406.78 | 51.69 | 20.51% | 28.15% | 16.89% | 0.02 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 | |
 RMD | 27.48B | 188.63 | 19.83 | 9.84% | 27.44% | 24.41% | 0.14 |
Compare AHCO vs Peers
AdaptHealth Corp. (AHCO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AHCO Income Statement
AdaptHealth Corp. (AHCO) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 192.56M | 345.28M | 529.64M | 1.06B | 2.45B | 2.97B | 3.2B | 3.26B | 3.24B | 2.86B |
Revenue Growth % | - | 79.31% | 53.4% | 99.45% | 132.35% | 21.02% | 7.73% | 1.9% | -0.49% | 8.78% |
Cost of Goods Sold | 162.9M | 285.2M | 440.7M | 898.6M | 2.01B | 2.55B | 2.52B | 2.58B | 2.68B | 1.99B |
COGS % of Revenue | 84.6% | 82.6% | 83.21% | 85.06% | 81.85% | 85.95% | 78.7% | 79.11% | 82.48% | - |
Gross Profit | 29.66M▲ 0% | 60.08M▲ 102.6% | 88.94M▲ 48.0% | 157.79M▲ 77.4% | 445.61M▲ 182.4% | 417.43M▼ 6.3% | 681.77M▲ 63.3% | 681.09M▼ 0.1% | 568.56M▼ 16.5% | 52.59M▲ 0% |
Gross Margin % | 15.4% | 17.4% | 16.79% | 14.94% | 18.15% | 14.05% | 21.3% | 20.89% | 17.52% | 1.84% |
Gross Profit Growth % | - | 102.56% | 48.05% | 77.41% | 182.41% | -6.32% | 63.33% | -0.1% | -16.52% | - |
Operating Expenses | 693 | 1.23M | 59.56M | 86.44M | 220M | 227.01M | 1.28B | 417.36M | 382.29M | -52.23M |
OpEx % of Revenue | 0% | 0.36% | 11.25% | 8.18% | 8.96% | 7.64% | 40% | 12.8% | 11.78% | - |
Selling, General & Admin | 693 | 1.04M | 56.49M | 89.35M | 167.5M | 162.13M | 190.09M | 359.24M | 382.29M | 385.95M |
SG&A % of Revenue | 0% | 0.3% | 10.67% | 8.46% | 6.82% | 5.46% | 5.94% | 11.02% | 11.78% | - |
Research & Development | 310K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | 0.16% | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 0 | 197.59K | 3.07M | -2.9M | 52.5M | 64.89M | 1.09B | 58.12M | 0 | -2M |
Operating Income | -690▲ 0% | -1.23M▼ 178699.4% | 29.38M▲ 2481.3% | 71.35M▲ 142.9% | 225.6M▲ 216.2% | 190.41M▼ 15.6% | -598.4M▼ 414.3% | 263.73M▲ 144.1% | 186.27M▼ 29.4% | 206.21M▲ 0% |
Operating Margin % | -0% | -0.36% | 5.55% | 6.75% | 9.19% | 6.41% | -18.7% | 8.09% | 5.74% | 7.21% |
Operating Income Growth % | - | -178699.42% | 2481.26% | 142.86% | 216.21% | -15.6% | -414.27% | 144.07% | -29.37% | - |
EBITDA | 27.82M | 49.38M | 91.94M | 153.79M | 483.66M | 613.85M | -177.81M | 629.07M | 599.31M | 503.9M |
EBITDA Margin % | 14.45% | 14.3% | 17.36% | 14.56% | 19.7% | 20.66% | -5.56% | 19.29% | 18.47% | 17.62% |
EBITDA Growth % | - | 77.52% | 86.21% | 67.26% | 214.49% | 26.92% | -128.97% | 453.79% | -4.73% | -16.46% |
D&A (Non-Cash Add-back) | 27.82M | 50.61M | 62.57M | 82.44M | 258.05M | 423.44M | 420.59M | 365.33M | 413.04M | 297.69M |
EBIT | -693 | 30.24M | 17.44M | -164.61M | 286.15M | 207.32M | -591.68M | 262.69M | 90.6M | 67.43M |
Net Interest Income | 0 | 0 | -39.3M | -41.43M | -95.19M | -109.41M | -130.3M | -126.67M | -105.75M | -77.35M |
Interest Income | 0 | 4.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 4.15M | 39.3M | 41.43M | 95.19M | 109.41M | 130.3M | 126.67M | 105.75M | 102.95M |
Other Income/Expense | 0 | -8.85M | -51.24M | -277.39M | -34.65M | -92.51M | -125.38M | -127.71M | -201.42M | -236.24M |
Pretax Income | -693▲ 0% | 2.92M▲ 420864.9% | -21.86M▼ 849.8% | -206.04M▼ 842.5% | 190.96M▲ 192.7% | 97.9M▼ 48.7% | -723.78M▼ 839.3% | 136.02M▲ 118.8% | -15.15M▼ 111.1% | -30.03M▲ 0% |
Pretax Margin % | -0% | 0.84% | -4.13% | -19.5% | 7.78% | 3.3% | -22.62% | 4.17% | -0.47% | -1.05% |
Income Tax | 0 | 829.81K | 739K | -11.96M | 32.81M | 24.77M | -49M | 41.24M | 50.88M | 44.8M |
Effective Tax Rate % | 0% | 28.46% | -3.38% | 5.8% | 17.18% | 25.3% | 6.77% | 30.32% | -335.78% | -149.19% |
Net Income | -693▲ 0% | 2.09M▲ 301123.7% | -21.34M▼ 1123.0% | -161.63M▼ 657.4% | 156.18M▲ 196.6% | 69.32M▼ 55.6% | -678.89M▼ 1079.4% | 90.42M▲ 113.3% | -70.79M▼ 178.3% | -79.63M▲ 0% |
Net Margin % | -0% | 0.6% | -4.03% | -15.3% | 6.36% | 2.33% | -21.21% | 2.77% | -2.18% | -2.78% |
Net Income Growth % | - | 301123.67% | -1123.01% | -657.38% | 196.62% | -55.62% | -1079.42% | 113.32% | -178.29% | -193.3% |
Net Income (Continuing) | -693 | 24.34M | -22.6M | -194.09M | 158.15M | 73.13M | -674.78M | 94.78M | -66.04M | -76M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | -34.09M | 2.87M | -26.96M | -74.04M | 4.78M | 6.6M | 8.21M | 6.97M | 7.76M | 7.41M |
EPS (Diluted) | 0.00▲ 0% | 0.07▲ 0% | 0.17▲ 154.5% | -1.23▼ 823.5% | 0.67▲ 154.5% | 0.50▼ 25.4% | -5.31▼ 1162.0% | 0.61▲ 111.5% | -0.52▼ 185.2% | -0.59▲ 0% |
EPS Growth % | - | - | 154.49% | -823.53% | 154.47% | -25.37% | -1162% | 111.49% | -185.25% | -203.51% |
EPS (Basic) | 0.00 | 0.07 | 0.17 | -1.23 | 1.12 | 0.52 | -5.32 | 0.62 | -0.52 | - |
Diluted Shares Outstanding | 31.25M | 31.25M | 72.38M | 52.49M | 133.03M | 138.99M | 134.42M | 135.53M | 135.15M | 135.78M |
Basic Shares Outstanding | 31.25M | 31.25M | 72.38M | 52.49M | 126.31M | 134.18M | 134.16M | 133.76M | 135.15M | 135.78M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
AHCO Balance Sheet
AdaptHealth Corp. (AHCO) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 119.82K | 1.11M | 181.41M | 363.25M | 670.06M | 585.31M | 649.02M | 755.79M | 728.9M | 687.48M |
Cash & Short-Term Investments | 119.82K | 947.1K | 76.88M | 99.96M | 149.63M | 46.27M | 77.13M | 109.75M | 106.14M | 47.96M |
Cash Only | 119.82K | 947.1K | 76.88M | 99.96M | 149.63M | 46.27M | 77.13M | 109.75M | 106.14M | 47.96M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 0 | 53.02M | 78.62M | 171.06M | 359.9M | 359.15M | 388.91M | 408.02M | 370.9M | 391.97M |
Days Sales Outstanding | - | 56.04 | 54.18 | 59.11 | 53.52 | 44.13 | 44.36 | 45.67 | 41.72 | 50.05 |
Inventory | 4.96M | 7.67M | 13.24M | 58.78M | 123.09M | 127.75M | 113.64M | 139.84M | 151.25M | 159.27M |
Days Inventory Outstanding | 11.12 | 9.82 | 10.96 | 23.88 | 22.36 | 18.26 | 16.47 | 19.78 | 20.63 | 27.93 |
Other Current Assets | 0 | -60.69M | 0 | 0 | 0 | 52.14M | 69.34M | 98.18M | 0 | 88.28M |
Total Non-Current Assets | 190.79K | 253.02M | 365.12M | 1.45B | 4.58B | 4.63B | 3.86B | 3.73B | 3.59B | 3.74B |
Property, Plant & Equipment | 35.57M | 61.6M | 63.56M | 110.47M | 546.34M | 622.01M | 637.53M | 618.36M | 674.22M | 795.08M |
Fixed Asset Turnover | 5.41x | 5.61x | 8.33x | 9.56x | 4.49x | 4.78x | 5.02x | 5.27x | 4.81x | 4.20x |
Goodwill | 38.63M | 202.44M | 266.79M | 998.81M | 3.51B | 3.55B | 2.72B | 2.68B | 2.54B | 2.57B |
Intangible Assets | 0 | 0 | 0 | 116.06M | 202.23M | 162.77M | 130.16M | 105.55M | 85.12M | 80.23M |
Long-Term Investments | 0 | -276.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | -74.01M | 253.02M | 6.85M | 16.48M | 15.1M | 22.41M | 21.13M | 17.58M | 19.12M | 18.8M |
Total Assets | 310.62K▲ 0% | 254.12M▲ 81713.0% | 546.54M▲ 115.1% | 1.81B▲ 231.8% | 5.25B▲ 189.5% | 5.22B▼ 0.6% | 4.51B▼ 13.6% | 4.49B▼ 0.5% | 4.32B▼ 3.8% | 4.42B▲ 0% |
Asset Turnover | 619.93x | 1.36x | 0.97x | 0.58x | 0.47x | 0.57x | 0.71x | 0.73x | 0.75x | 0.65x |
Asset Growth % | - | 81713% | 115.07% | 231.81% | 189.53% | -0.59% | -13.62% | -0.48% | -3.8% | -9.58% |
Total Current Liabilities | 286.31K | 699.39K | 154.05M | 422.05M | 499.81M | 456.21M | 537M | 566.99M | 712.39M | 743.29M |
Accounts Payable | 60.51K | 40.77K | 79.24M | 191.04M | 248.03M | 222.5M | 211.5M | 284.6M | 352.38M | 0 |
Days Payables Outstanding | 0.14 | 0.05 | 65.63 | 77.6 | 45.06 | 31.81 | 30.65 | 40.27 | 48.06 | 47.43 |
Short-Term Debt | 174.24K | 27.9M | 1.72M | 8.15M | 20M | 35M | 53.37M | 16.25M | 20.31M | 78.27M |
Deferred Revenue (Current) | 0 | 7.51M | 9.56M | 11.04M | 31.37M | 31.64M | 38.57M | 34.94M | 0 | 116.14M |
Other Current Liabilities | -9.95M | -27.9M | 20.3M | 126.37M | 43.19M | 19.86M | 14.68M | 33.55M | 291.27M | 665.01M |
Current Ratio | 0.42x | 1.58x | 1.18x | 0.86x | 1.34x | 1.28x | 1.21x | 1.33x | 1.02x | 0.92x |
Quick Ratio | -16.92x | -9.39x | 1.09x | 0.72x | 1.09x | 1.00x | 1.00x | 1.09x | 0.81x | 0.71x |
Cash Conversion Cycle | - | 65.81 | -0.48 | 5.39 | 30.82 | 30.58 | 30.17 | 25.19 | 14.29 | 30.54 |
Total Non-Current Liabilities | 54.91M | 7.88M | 458.27M | 1.11B | 2.68B | 2.61B | 2.5B | 2.34B | 2.08B | 2.17B |
Long-Term Debt | 52.7M | 127.09M | 395.11M | 776.57M | 2.18B | 2.15B | 2.09B | 1.96B | 1.72B | 123.53M |
Capital Lease Obligations | 0 | 172.47K | 233.14K | 0 | 120.18M | 108.34M | 108.28M | 104.91M | 118.07M | 315.64M |
Deferred Tax Liabilities | 0 | 3.78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | -52.7M | -119.39M | 62.92M | 334.01M | 380.25M | 344M | 302.09M | 272.02M | 243.8M | 2.04B |
Total Liabilities | 286.31K | 8.57M | 612.32M | 1.53B | 3.18B | 3.06B | 3.04B | 2.91B | 2.79B | 2.91B |
Total Debt | 174.24K | 155.17M | 416.82M | 807M | 2.37B | 2.33B | 2.29B | 2.13B | 1.9B | 201.81M |
Net Debt | 54.42K | 154.22M | 339.94M | 707.03M | 2.22B | 2.28B | 2.22B | 2.02B | 1.8B | 153.84M |
Debt / Equity | - | 0.62x | - | 2.87x | 1.15x | 1.08x | 1.56x | 1.35x | 1.25x | 0.13x |
Debt / EBITDA | 0.01x | 3.14x | 4.53x | 5.25x | 4.90x | 3.79x | - | 3.39x | 3.18x | 0.40x |
Net Debt / EBITDA | 0.00x | 3.12x | 3.70x | 4.60x | 4.59x | 3.72x | - | 3.21x | 3.00x | 0.31x |
Interest Coverage | - | 7.29x | 0.44x | -3.97x | 3.01x | 1.89x | -4.54x | 2.07x | 0.86x | 0.65x |
Total Equity | -34.07M▲ 0% | 248.42M▲ 829.2% | -65.78M▼ 126.5% | 280.85M▲ 526.9% | 2.07B▲ 635.9% | 2.16B▲ 4.4% | 1.47B▼ 32.0% | 1.58B▲ 7.6% | 1.53B▼ 3.3% | 1.51B▲ 0% |
Equity Growth % | - | 829.18% | -126.48% | 526.93% | 635.88% | 4.41% | -32.03% | 7.6% | -3.28% | 6.35% |
Book Value per Share | -1.09 | 7.95 | -0.91 | 5.35 | 15.54 | 15.52 | 10.91 | 11.64 | 11.29 | 11.15 |
Total Shareholders' Equity | 24.31K | 245.55M | -38.82M | 354.89M | 2.06B | 2.15B | 1.46B | 1.57B | 1.52B | 1.51B |
Common Stock | 719 | 240.55M | 7K | 9K | 13K | 13K | 13K | 13K | 13K | 14K |
Retained Earnings | -693 | 2.09M | -40.26M | -199.2M | -43.02M | 26.3M | -652.6M | -562.18M | -632.97M | -649.01M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | -13.99M | -43.27M | -25.55M | -25.55M | 0 |
Accumulated OCI | 0 | 0 | 1.43M | -4.41M | -2.35M | 8.69M | 4.36M | 2.25M | 78K | 0 |
Minority Interest | -34.09M | 2.87M | -26.96M | -74.04M | 4.78M | 6.6M | 8.21M | 6.97M | 7.76M | 7.41M |
AHCO Cash Flow Statement
AdaptHealth Corp. (AHCO) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 45.93M | 68.43M | 60.42M | 195.63M | 275.68M | 373.87M | 480.67M | 541.84M | 601.77M | 506.24M |
Operating CF Margin % | 23.85% | 19.82% | 11.41% | 18.52% | 11.23% | 12.59% | 15.02% | 16.62% | 18.55% | - |
Operating CF Growth % | - | 48.98% | -11.7% | 223.8% | 40.92% | 35.62% | 28.57% | 12.73% | 11.06% | -84.85% |
Net Income | -690 | 2.09M | 12.24M | -194.09M | 158.15M | 73.13M | -678.89M | 94.78M | -66.04M | -79.63M |
Depreciation & Amortization | 27.82M | 50.61M | 11.28M | 82.44M | 258.05M | 351.18M | 420.59M | 365.33M | 381.93M | 421.25M |
Stock-Based Compensation | 48.75K | 884K | 11.07M | 18.67M | 25.32M | 22.4M | 22.47M | 14.88M | 21.88M | 11.27M |
Deferred Taxes | 0 | -2.88M | 895.3K | -21.1M | 22.38M | 18.04M | -62.59M | 32.05M | 47.16M | 42.34M |
Other Non-Cash Items | 12.02M | 65.91M | 43.12M | 232.8M | -34.92M | 17.12M | 804.2M | 60.85M | 150.26M | 23.96M |
Working Capital Changes | 690 | 429.32K | -18.19M | 76.91M | -153.31M | -108M | -25.11M | -26.06M | 66.58M | 70.68M |
Change in Receivables | -3.04M | -21.34M | -11.81M | -29.52M | -29.69M | -209K | -28.86M | -26.22M | 30.99M | 25.35M |
Change in Inventory | 1.14M | 2.31M | -14.26M | -19.43M | -14.92M | -6.3M | 15.53M | -28.07M | -11.49M | -28.4M |
Change in Payables | 0 | -19.73K | 8.78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Investing | -15.08M | -248.87M | -386K | -815.7M | -1.82B | -411.17M | -357.28M | -310.27M | -303.19M | -207.6M |
Capital Expenditures | -6.85M | -9.95M | -21.33M | -39.76M | -203.31M | -391.42M | -337.46M | -306.06M | -382.39M | -286.8M |
CapEx % of Revenue | 3.56% | 2.88% | 4.03% | 3.76% | 8.28% | 13.18% | 10.55% | 9.39% | 11.78% | 10.03% |
Acquisitions | -8.51M | -86.33M | 569K | -769.34M | -1.62B | -19.02M | -19.69M | -9.54M | -42.38M | -124.12M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 280.51K | -238.92M | 20.38M | 0 | 0 | 0 | 0 | 5.32M | 121.58M | 203.32M |
Cash from Financing | 119.82K | 251.33M | -13.89M | 643.15M | 1.6B | -66.05M | -92.53M | -198.95M | -302.19M | -246.15M |
Debt Issued (Net) | -29.69M | -174.24K | 205.66M | 354.74M | 1.4B | -36.18M | -51.77M | -179.87M | -268.48M | -154.32M |
Equity Issued (Net) | 0 | 250M | 101.29M | 323.33M | 278.85M | -13.99M | -29.27M | 0 | 1.21M | -108K |
Dividends Paid | 0 | 0 | -250M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 25K | 0 | -23.71M | -44.27M | 0 | -13.99M | -29.27M | 0 | 0 | -755K |
Other Financing | -573.96K | 1.51M | -70.84M | -34.92M | -75.68M | -15.88M | -11.48M | -19.08M | -34.92M | -91.72M |
Net Change in Cash | -3.56M▲ 0% | 827.28K▲ 123.2% | -875K▼ 205.8% | 23.08M▲ 2738.2% | 49.66M▲ 115.1% | -103.36M▼ 308.1% | 30.86M▲ 129.9% | 32.62M▲ 5.7% | -3.61M▼ 111.1% | -5.69M▲ 0% |
Free Cash Flow | 39.08M▲ 0% | 58.48M▲ 49.6% | 39.09M▼ 33.2% | 155.88M▲ 298.8% | 72.37M▼ 53.6% | -17.56M▼ 124.3% | 143.2M▲ 915.7% | 235.78M▲ 64.7% | 219.38M▼ 7.0% | 219.44M▲ 0% |
FCF Margin % | 20.29% | 16.94% | 7.38% | 14.76% | 2.95% | -0.59% | 4.47% | 7.23% | 6.76% | 7.67% |
FCF Growth % | - | 49.64% | -33.16% | 298.81% | -53.57% | -124.26% | 915.69% | 64.65% | -6.96% | -20.08% |
FCF per Share | 1.25 | 1.87 | 0.54 | 2.97 | 0.54 | -0.13 | 1.07 | 1.74 | 1.62 | 1.62 |
FCF Conversion (FCF/Net Income) | -66277.97x | 32.80x | -2.83x | -1.21x | 1.77x | 5.39x | -0.71x | 5.99x | -8.50x | -2.76x |
Interest Paid | 0 | 0 | 23.07M | 35.77M | 73.63M | 108.89M | 126.23M | 122.07M | 0 | 0 |
Taxes Paid | 0 | 0 | 1.32M | 7.48M | 14.79M | 14.95M | 14.76M | 14.14M | 0 | 0 |
AHCO Key Ratios
AdaptHealth Corp. (AHCO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 1.95% | -23.37% | -150.31% | 13.31% | 3.28% | -37.46% | 5.94% | -4.56% | -5.09% |
Return on Invested Capital (ROIC) | -0.5% | 6.51% | 8.48% | 6.41% | 3.27% | -11.05% | 5.43% | 4.04% | 5.19% |
Gross Margin | 17.4% | 16.79% | 14.94% | 18.15% | 14.05% | 21.3% | 20.89% | 17.52% | 1.84% |
Net Margin | 0.6% | -4.03% | -15.3% | 6.36% | 2.33% | -21.21% | 2.77% | -2.18% | -2.78% |
Debt / Equity | 0.62x | - | 2.87x | 1.15x | 1.08x | 1.56x | 1.35x | 1.25x | 0.13x |
Interest Coverage | 7.29x | 0.44x | -3.97x | 3.01x | 1.89x | -4.54x | 2.07x | 0.86x | 0.65x |
FCF Conversion | 32.80x | -2.83x | -1.21x | 1.77x | 5.39x | -0.71x | 5.99x | -8.50x | -2.76x |
Revenue Growth | 79.31% | 53.4% | 99.45% | 132.35% | 21.02% | 7.73% | 1.9% | -0.49% | 8.78% |
Related:AHCO Dividend History·AHCO Revenue History·AHCO Price History·AHCO P/E History·AHCO Financial Ratios·AHCO Institutional Holders
AHCO SEC Filings & Documents
AdaptHealth Corp. (AHCO) SEC filings — annual & quarterly reports (10-K, 10-Q)
AHCO Frequently Asked Questions
AdaptHealth Corp. (AHCO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
AdaptHealth Corp. (AHCO) reported $2.86B in revenue for fiscal year 2025. This represents a 1386% increase from $192.6M in 2017.
AdaptHealth Corp. (AHCO) saw revenue decline by 0.5% over the past year.
AdaptHealth Corp. (AHCO) reported a net loss of $79.6M for fiscal year 2025.
Dividend & Returns
AdaptHealth Corp. (AHCO) has a return on equity (ROE) of -4.6%. Negative ROE indicates the company is unprofitable.
AdaptHealth Corp. (AHCO) generated $219.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.